We are live on ! Find out more
LICN icon

Lichen China

1 hedge funds and large institutions have $2.66K invested in Lichen China in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0%0% (-0%)

75% less funds holding

Funds holding: 41 (-3)

95% less capital invested

Capital invested by funds: $57.5K → $2.66K (-$54.9K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
-3
Holders Change %
-75%
% of All Funds
0.02%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
1
UBS Group
Switzerland
$2.66K -$3.32K -16 -59%
CD
2
Chapin Davis
Maryland
-$17.5K -66 Closed
Two Sigma Investments
3
Two Sigma Investments
New York
-$16.9K -64 Closed
Renaissance Technologies
4
Renaissance Technologies
New York
-$16K -59 Closed

LICN Hedge Fund Activity: Q3 2023 in Review

1 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Lichen China (LICN) for Q3 2023, worth a combined $2.66K — down 95% from $57.5K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of LICN and 0 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Chapin Davis, exiting entirely with an estimated $17.5K sold.

  • 1 institutional investor held Lichen China (LICN) as of Q3 2023, down from 4 in Q2 2023.
  • Funds reported $2.66K of Lichen China stock for Q3 2023, down 95% quarter-over-quarter.
  • 0 funds opened new Lichen China positions in Q3 2023 and 3 closed out, a net change of -3 holders.
  • The largest Lichen China seller in Q3 2023 was Chapin Davis, an estimated $17.5K sold.

Based on aggregated 13F filings for Q3 2023.